Available and affordable complementary treatments for COVID-19: From hypothesis to pilot studies and the need for implementation

Jean Bousquet; Tari Haahtela; Hubert Blain; Wienczyslawa Czarlewski; Torsten Zuberbier; Anna Bedbrook; Alvaro A. Cruz; Joao A. Fonseca; Ludger Klimek; Piotr Kuna; Boleslaw Samolinski; Arunas Valiulis; Antoine Lemaire; Josep M. Anto

doi:10.1002/clt2.12127

Available and affordable complementary treatments for COVID-19: From hypothesis to pilot studies and the need for implementation

Jean Bousquet, Tari Haahtela, Hubert Blain, Wienczyslawa Czarlewski, Torsten Zuberbier, Anna Bedbrook, Alvaro A. Cruz, Joao A. Fonseca, Ludger Klimek, Piotr Kuna, Boleslaw Samolinski, Arunas Valiulis, Antoine Lemaire, Josep M. Anto

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

Alkuperäiskieli	englanti
Artikkeli	12127
Lehti	Clinical and Translational Allergy
Vuosikerta	12
Numero	3
Sivumäärä	7
ISSN	2045-7022
DOI - pysyväislinkit	https://doi.org/10.1002/clt2.12127
Tila	Julkaistu - maalisk. 2022
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Tieteenalat

3121 Yleislääketiede, sisätaudit ja muut kliiniset lääketieteet

Pääsy asiakirjaan

10.1002/clt2.12127

Clinical Translational All - 2022 - Bousquet - Available and affordable complementary treatments for COVID‐19 FromLopullinen julkaistu versio, 451 KBLisenssi: CC BY

Siteeraa tätä

Bousquet, J., Haahtela, T., Blain, H., Czarlewski, W., Zuberbier, T., Bedbrook, A., Cruz, A. A., Fonseca, J. A., Klimek, L., Kuna, P., Samolinski, B., Valiulis, A., Lemaire, A., & Anto, J. M. (2022). Available and affordable complementary treatments for COVID-19: From hypothesis to pilot studies and the need for implementation. Clinical and Translational Allergy, 12(3), [12127]. https://doi.org/10.1002/clt2.12127

@article{c09dc3d072e843058608539336dafa6d,

title = "Available and affordable complementary treatments for COVID-19: From hypothesis to pilot studies and the need for implementation",

keywords = "broccoli, COVID-19, curcumin, Nrf2, TRP channel, DESENSITIZATION, CURCUMIN, STRATEGY, 3121 General medicine, internal medicine and other clinical medicine",

author = "Jean Bousquet and Tari Haahtela and Hubert Blain and Wienczyslawa Czarlewski and Torsten Zuberbier and Anna Bedbrook and Cruz, {Alvaro A.} and Fonseca, {Joao A.} and Ludger Klimek and Piotr Kuna and Boleslaw Samolinski and Arunas Valiulis and Antoine Lemaire and Anto, {Josep M.}",

year = "2022",

month = mar,

doi = "10.1002/clt2.12127",

language = "English",

volume = "12",

journal = "Clinical and Translational Allergy",

issn = "2045-7022",

publisher = "BMC",

number = "3",

}

Bousquet, J, Haahtela, T, Blain, H, Czarlewski, W, Zuberbier, T, Bedbrook, A, Cruz, AA, Fonseca, JA, Klimek, L, Kuna, P, Samolinski, B, Valiulis, A, Lemaire, A & Anto, JM 2022, 'Available and affordable complementary treatments for COVID-19: From hypothesis to pilot studies and the need for implementation', Clinical and Translational Allergy, Vuosikerta 12, Nro 3, 12127. https://doi.org/10.1002/clt2.12127

TY - JOUR

T1 - Available and affordable complementary treatments for COVID-19

T2 - From hypothesis to pilot studies and the need for implementation

AU - Bousquet, Jean

AU - Haahtela, Tari

AU - Blain, Hubert

AU - Czarlewski, Wienczyslawa

AU - Zuberbier, Torsten

AU - Bedbrook, Anna

AU - Cruz, Alvaro A.

AU - Fonseca, Joao A.

AU - Klimek, Ludger

AU - Kuna, Piotr

AU - Samolinski, Boleslaw

AU - Valiulis, Arunas

AU - Lemaire, Antoine

AU - Anto, Josep M.

PY - 2022/3

Y1 - 2022/3

KW - broccoli

KW - COVID-19

KW - curcumin

KW - Nrf2

KW - TRP channel

KW - DESENSITIZATION

KW - CURCUMIN

KW - STRATEGY

KW - 3121 General medicine, internal medicine and other clinical medicine

U2 - 10.1002/clt2.12127

DO - 10.1002/clt2.12127

M3 - Article

VL - 12

JO - Clinical and Translational Allergy

JF - Clinical and Translational Allergy

SN - 2045-7022

IS - 3

M1 - 12127

ER -